Drug discovery is alluded to as the method involved with recognizing and fostering a compound that has pharmacological movement and is helpful in treating infection. Drug discovery is an intricate and extended strategy that returns through different stages to create an item that is adequate, safe, and holds administrative consistency. The course of drug discovery and informatics has been changing, with the reception of different computational techniques aiding the plan of novel drug up-and-comers quickly and at lower costs.

Drug discovery cycles should proceed unendingly, considering that infection science has consistently a neglected need. Around the world, patients and medical services suppliers are consistently in the quest for new treatments incorporating drugs with better adequacy and wellbeing profiles. This inclination has been a key support for the drug discovery administrations market to advance. Distinguishing sickness-changing components, or drug focuses as they are prevalently called, is critical to drug discovery processes, and the specialist co-ops have extended their stockpile in handling the intricacies in question. They have explicitly fortified their solidarity in target and stages. Pharma and bio-pharma organizations in the market have seen gigantic income potential in pharmacology studies and screening measures. The interest for coordinated drug discovery administrations, beginning from the distinguishing proof of drug processes, has improved the serious scene in the drug discovery administrations market.

The presence of cutting edge medical services area foundation is probably going to assist with expanding the development of the North American and European business sectors before long. Conventional drug improvement and testing and more prominent examination of the endorsement interaction are available critical issues, both for the drug business and for patients who frantically trust that new drugs will treat their diseases. This component is ascribed to the versatility of the new and progressed advancement informatics.

The Asia Pacific is a rewarding area of the market. The drug discovery administrations market in the locale is expected to extend at a fast development rate during the figure time frame. An expansion in government drives is projected to help the portion of the overall industry of Asia Pacific. An enormous populace base and ascend in the rate of irresistible sicknesses are ascribed to the expanded interest for drug discovery informatics in nations like India, China, Japan, Singapore, and others. They are projected to offer huge freedoms to the drug discovery administrations market before very long.

Drug Discovery Informatics Market: Snapshot

Drug discovery informatics is a complex process that requires the generation of very large information, and data. Through application of modern computational, and engineering approaches the models are simulated, analyzed, and visualized. A study of dynamical complex interactions between components of biological systems will enable the understanding of the behavior of these systems at each level of their organization. For the better understanding of this, quantitative development of the biophysically, biochemically, structurally detailed mathematical models have been developed. The global drug discovery informatics market was valued approximately US$ 2.0 Bn in 2016 and is anticipated to register CAGR of over 17.0% from 2017 to 2025 to reach value of approximately US$ 7.8 Bn by 2025. The cost and time of drug discovery are reduced to a very large extent in comparison with the traditional drug discovery process, these drivers are likely to fuel expansion of the global drug discovery informatics market from 2017 to 2025.

Now the drug discovery informatics computer applications are used by the healthcare industry and most of the pharmaceutical, and biotechnological companies have employed scientists dedicated to use drug discovery informatics for a decade or more. There is continuous growth in the number of complicated biological targets, shifts to outsourcing the drug discovery informatics, increasing expectations for project decisions from executive management. The availability of the new technologies promotes collaboration in the discoveries between the organizations among the project teams. The drug discovery informatics provides higher autonomy to more researchers, and also the laboratory scientists, and better decision making tools.

global drug discovery informatics market

The technological advancements in the drug discovery informatics that are employed by computational informatics are leading to developments in scientific innovation. The increasing number of uses of the drug discovery informatics such as the scientists use it to communicate their ideas with their colleagues in computational chemistry, and biology to design small parallel libraries, and to conduct their own preliminary analysis of interactions between the ligand and receptor are driving the growth of the global drug discovery informatics market.

The Global Drug Discovery Informatics Market is classified on the basis of product, mode, function, end-user, and region. Based on the product, the market is divided into development informatics, and discovery informatics. The discovery informatics segment dominated the market in terms of revenue in 2016, due to its cost benefits. In terms of mode, the market can be categorized into outsourced informatics, and in-house informatics. Outsourced informatics is estimated to dominate in terms of revenue in 2016 owing to the rise in collaborations and lead drug discovery projects between pharmaceutical companies, and IT market participants. Based on function the market can be classified into sequencing and target data analysis, docking, lead generation informatics, identification & validation informatics, molecular modeling, and others. Sequencing and target data analysis is estimated to dominate the market in 2016, owing to reduced cost of sequencing informatics. In terms of end-user the market can be divided into contract research organizations, pharmaceutical & biotechnology companies, and others. Contract research organizations (CROs) segment is estimated to dominate in 2016, owing to increasing number of CROs all over the world for drug discovery.

Geographically, North America held the large market share in 2016, due to increasing technological advancements in the drug discovery informatics in the region. Asia pacific is anticipated to grow at the fast growth rate during the forecast period. This is subjected to high adoption of drug discovery informatics that has led to major share held by Asia Pacific in the global drug discovery informatics market. Middle East & Africa and Latin America are expected to grow during the forecast period. Rising awareness regarding the drug discovery informatics in the regions is anticipated to grow the demand for the drug discovery informatics during the forecast period.

Key companies profiled in the report include Charles River Laboratories International, Inc., Thermo Fisher Scientific, PerkinElmer Inc., Biogen Inc., Boehringer Ingelheim GmbH, Insilico Medicine, Inc., International Business Machines Corporation, Schrödinger, LLC, Albany Molecular Research Inc. (AMRI), and Certara, L.P. These players are adopting the growth strategies that increase their product offerings, strengthen their geographical reach, increase customer base and garner market share. For instance, In September 2016, Charles River Laboratories International, Inc. acquired Agilux Laboratories, a contract based research organization which provides bio analytical services.

Drug Discovery Informatics Market: Overview

This report on the Global Drug Discovery Informatics Market analyzes the current and future scenario of the global market.  Rise in private and public funding for drug discovery informatics, and increasing number of uses of the drug discovery informatics such as the scientists use it to communicate their ideas with their colleagues in computational chemistry, and biology to design small parallel libraries, and to conduct their own preliminary analysis of interactions between the ligand and receptor are some of the factors expected to drive the growth of global Drug Discovery Informatics market during the forecast period.

The global Drug Discovery Informatics market report comprises an elaborate executive summary, which includes market snapshot that provides information about various segments.  It also provides information and data analysis of the global market with respect to the segments based on of product, mode, function, end-user, and geography.  A detailed qualitative analysis of drivers and restraints, opportunities and trends have been provided in the market overview section.  Additionally, the section comprises Healthcare IT expenditure to help understand the scope in the market.  This section also provides market attractiveness analysis in terms of geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global drug discovery informatics market.  

Based on the product, the market is divided into development informatics, and discovery informatics. The discovery informatics segment dominated the market in terms of revenue in 2016, due to its cost benefits. Development informatics is anticipated to grow during the forecast period owing to the technological advancements in the development informatics. In terms of mode the market can be categorized into outsourced informatics, and in-house informatics. Outsourced informatics is estimated to dominate in terms of revenue in 2016 owing to the rise in collaborations and lead drug discovery projects between pharmaceutical companies, and IT market participants. In-house informatics is anticipated to grow in the coming years due to rise in the awareness regarding the time and cost benefits in the long run for the biotechnological and pharmaceutical companies.

Drug Discovery Informatics Market: Key Segments

Based on function the market can be classified into sequencing and target data analysis, docking, lead generation informatics, identification & validation informatics, molecular modeling, and others. Sequencing and target data analysis is estimated to dominate the market in 2016, owing to reduced cost of sequencing informatics. Molecular modeling segment is anticipated to grow during the forecast period owing to the increasing number of applications of small molecules in drug discovery. In terms of end-user the market can be divided into contract research organizations, pharmaceutical & biotechnology companies, and others. Contract research organizations (CROs) segment is estimated to dominate in 2016, owing to increasing number of CROs all over the world for drug discovery. Pharmaceutical and biotechnological companies segment is anticipated to grow during the forecast period owing to the long term time and cost benefits of the drug discovery informatics.

Geographically, the global drug discovery informatics market has been categorized into five major regions and the key countries in the respective region: North America (US  and Canada), Europe (Germany, France, Italy, Spain, UK, and Rest of Europe), Asia Pacific (China, Japan, India, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa).  

The report also profiles major players in the global drug discovery informatics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments.  Major players profiled in this report include Charles River Laboratories International, Inc., Thermo Fisher Scientific, PerkinElmer Inc., Biogen Inc., Boehringer Ingelheim GmbH, Insilico Medicine, Inc., International Business Machines Corporation, Schrödinger, LLC, Albany Molecular Research Inc. (AMRI), and Certara, L.P.

The global drug discovery informatics market has been segmented as below:

Product

  • Discovery Informatics
  • Development Informatics

Mode

  • In-House Informatics
  • Outsourced Informatics

Function

  • Sequencing and Target Data Analysis
  • Docking
  • Lead Generation Informatics
  • Identification & Validation Informatics
  • Molecular Modeling
  • Others

End-user

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Others

Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

1. Preface
     1.1. Market Segmentation
     1.2. Key Research Objectives
     1.3. Research Highlights

2. Assumptions

3. Research Approach & Methodology
     3.1. Secondary Research Methodology
     3.2. Primary Research Methodology
     3.3. Analysis Research Methodology
     3.4. Final Report & Conclusions Research Methodology

4. Executive Summary: Global Drug Discovery Informatics Market

5. Market Overview
     5.1. Overview
     5.2. Key Industry Events and Developments

6. Market Dynamics
     6.1. Drivers and Restraints Snapshot Analysis
     6.2. Drivers
     6.3. Restraints
     6.4. Opportunity
     6.5. Key Trends
     6.6. Healthcare IT spending, by Countries
     6.6. Global Drug Discovery Informatics Market Forecast and Analysis
     6.7. Global Drug Discovery Informatics Market Outlook

7. Global Drug Discovery Informatics Market Analysis and Forecasts, By Product 
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Market Value Forecast by Product, 2015–2025
            7.3.1. Discovery Informatics
            7.3.2. Development Informatics
     7.4. Product Comparison Matrix
     7.5. Market Attractiveness by Product

8. Global Drug Discovery Informatics Market Analysis and Forecasts, By Mode 
     8.1. Introduction & Definition
     8.2. Key Findings / Developments
     8.3. Market Value Forecast by Mode, 2015–2025
            8.3.1. In-House Informatics
            8.3.2. Outsourced Informatics
     8.4. Mode Comparison Matrix
     8.5. Market Attractiveness by Mode 

9. Global Drug Discovery Informatics Market Analysis and Forecasts, By Function 
     9.1. Introduction & Definition
     9.2. Key Findings / Developments
     9.3. Market Value Forecast by Function, 2015–2025
            9.3.1. Sequencing and Target Data Analysis
            9.3.2. Docking
            9.3.3. Lead Generation Informatics
            9.3.4. Identification & Validation Informatics
            9.3.5. Molecular Modeling
            9.3.6. Others
     9.4. Function Comparison Matrix
     9.5. Market Attractiveness by Function 

10. Global Drug Discovery Informatics Market Analysis and Forecasts, By End-User 
     10.1. Introduction & Definition
     10.2. Key Findings / Developments
     10.3. Market Value Forecast by End-User, 2015–2025
            10.3.1. Pharmaceutical & Biotechnology Companies
            10.3.2. Contract Research Organizations
            10.3.3. Others
     10.4. End-User Comparison Matrix
     10.5. Market Attractiveness by End-User

11. Global Drug Discovery Informatics Market Analysis and Forecasts, By Region
     11.1. Global Drug Discovery Informatics Market Snapshot, by Country
     11.2. Market Value Forecast by Region
            11.2.1. North America 
            11.2.2. Europe 
            11.2.3. Asia Pacific
            11.2.4. Latin America 
            11.2.5. Middle East & Africa 
     11.3. Market Attractiveness by Country/Region

12. North America Global Drug Discovery Informatics Market Analysis and Forecast
     12.1. Key Findings
     12.2. North America Global Drug Discovery Informatics Market Overview
     12.3. Market Value Share Analysis by Product, 2015–2025
            12.3.1. Discovery Informatics
            12.3.2. Development Informatics
     12.4. Market Value Share Analysis by Mode, 2015–2025
            12.4.1. In-House Informatics
            12.4.2. Outsourced Informatics
     12.5. Market Value Share Analysis by Function, 2015–2025
            12.5.1. Sequencing and Target Data Analysis
            12.5.2. Docking
            12.5.3. Lead Generation Informatics
            12.5.4. Identification & Validation Informatics
            12.5.5. Molecular Modeling
            12.5.6. Others
     12.6. Market Value Share Analysis by End-User, 2015–2025
            12.6.1. Pharmaceutical & Biotechnology Companies
            12.6.2. Contract Research Organizations
            12.6.3. Others
     12.7. Market Value Share Analysis by Country, 2015–2025
            12.7.1. U.S.
            12.7.2. Canada
     12.8. Market Attractiveness Analysis 
            12.8.1. By Product
            12.8.2. By Mode 
            12.8.3. By Function 
            12.8.4. By End-User
            12.8.5. By Country
     12.9. Market Trends

13. Europe Global Drug Discovery Informatics Market Analysis and Forecast
     13.1. Key Findings
     13.2. Europe Global Drug Discovery Informatics Market Overview
     13.3. Market Value Share Analysis by Product, 2015–2025
            13.3.1. Discovery Informatics
            13.3.2. Development Informatics
     13.4. Market Value Share Analysis by Mode, 2015–2025
            13.4.1. In-House Informatics
            13.4.2. Outsourced Informatics
     13.5. Market Value Share Analysis by Function, 2015–2025
            13.5.1. Sequencing and Target Data Analysis
            13.5.2. Docking
            13.5.3. Lead Generation Informatics
            13.5.4. Identification & Validation Informatics
            13.5.5. Molecular Modeling
            13.5.6. Others
     13.6. Market Value Share Analysis by End-User, 2015–2025
            13.6.1. Pharmaceutical & Biotechnology Companies
            13.6.2. Contract Research Organizations
            13.6.3. Others
     13.7. Market Value Share Analysis by Country, 2015–2025
            13.7.1. Germany
            13.7.2. France
            13.7.3. Italy
            13.7.4. Spain
            13.7.5. UK
            13.7.6. Rest of Europe
     13.8. Market Attractiveness Analysis 
            13.8.1. By Product
            13.8.2. By Mode 
            13.8.3. By Function 
            13.8.4. By End-User
            13.8.5. By Country
     13.9. Market Trends

14. Asia Pacific Global Drug Discovery Informatics Market Analysis and Forecast
     14.1. Key Findings
     14.2. Asia Pacific Global Drug Discovery Informatics Market Overview
     14.3. Market Value Share Analysis by Product, 2015–2025
            14.3.1. Discovery Informatics
            14.3.2. Development Informatics
     14.4. Market Value Share Analysis by Mode, 2015–2025
            14.4.1. In-House Informatics
            14.4.2. Outsourced Informatics
     14.5. Market Value Share Analysis by Function, 2015–2025
            14.5.1. Sequencing and Target Data Analysis
            14.5.2. Docking
            14.5.3. Lead Generation Informatics
            14.5.4. Identification & Validation Informatics
            14.5.5. Molecular Modeling
            14.5.6. Others
     14.6. Market Value Share Analysis by End-User, 2015–2025
            14.6.1. Pharmaceutical & Biotechnology Companies
            14.6.2. Contract Research Organizations
            14.6.3. Others
     14.7. Market Value Share Analysis by Country, 2015–2025
            14.7.1. China
            14.7.2. Japan
            14.7.3. India
            14.7.4. Australia & New Zealand
            14.7.5. Rest of Asia Pacific
     14.8. Market Attractiveness Analysis 
            14.8.1. By Product
            14.8.2. By Mode 
            14.8.3. By Function 
            14.8.4. By End-User
            14.8.5. By Country
     14.9. Market Trends

15. Latin America Global Drug Discovery Informatics Market Analysis and Forecast
     15.1. Key Findings
     15.2. Latin America Global Drug Discovery Informatics Market Overview
     15.3. Market Value Share Analysis by Product, 2015–2025
            15.3.1. Discovery Informatics
            15.3.2. Development Informatics
     15.4. Market Value Share Analysis by Mode, 2015–2025
            15.4.1. In-House Informatics
            15.4.2. Outsourced Informatics
     15.5. Market Value Share Analysis by Function, 2015–2025
            15.5.1. Sequencing and Target Data Analysis
            15.5.2. Docking
            15.5.3. Lead Generation Informatics
            15.5.4. Identification & Validation Informatics
            15.5.5. Molecular Modeling
            15.5.6. Others
     15.6. Market Value Share Analysis by End-User, 2015–2025
            15.6.1. Pharmaceutical & Biotechnology Companies
            15.6.2. Contract Research Organizations
            15.6.3. Others
     15.7. Market Value Share Analysis by Country, 2015–2025
            15.7.1. Brazil
            15.7.2. Mexico
            15.7.3. Rest of Latin America
     15.8. Market Attractiveness Analysis 
            15.8.1. By Product
            15.8.2. By Mode 
            15.8.3. By Function 
            15.8.4. By End-User
            15.8.5. By Country
     15.9. Market Trends

16. Middle East & Africa Global Drug Discovery Informatics Market Analysis and Forecast
     16.1. Key Findings
     16.2. Middle East & Africa Global Drug Discovery Informatics Market Overview
     16.3. Market Value Share Analysis by Product, 2016–2025
            16.3.1. Discovery Informatics
            16.3.2. Development Informatics
     16.4. Market Value Share Analysis by Mode, 2016–2025
            16.4.1. In-House Informatics
            16.4.2. Outsourced Informatics
     16.5. Market Value Share Analysis by Function, 2016–2025
            16.5.1. Sequencing and Target Data Analysis
            16.5.2. Docking
            16.5.3. Lead Generation Informatics
            16.5.4. Identification & Validation Informatics
            16.5.5. Molecular Modeling
            16.5.6. Others
     16.6. Market Value Share Analysis by End-User, 2016–2025
            16.6.1. Pharmaceutical & Biotechnology Companies
            16.6.2. Contract Research Organizations
            16.6.3. Others
     16.7. Market Value Share Analysis by Country, 2016–2025
            16.7.1. GCC Countries
            16.7.2. South Africa
            16.7.3. Rest of Middle East & Africa
     16.8. Market Attractiveness Analysis 
            16.8.1. By Product
            16.8.2. By Mode 
            16.8.3. By Function 
            16.8.4. By End-User
            16.8.5. By Country
     16.9. Market Trends

17. Competition Landscape
     17.1. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
            17.1.1. Charles River Laboratories International, Inc.
                      17.1.1.1. Company Description
                      17.1.1.2. Financial Overview
                      17.1.1.3. Strategic Overview
                      17.1.1.4. Recent Developments
                      17.1.1.5. SWOT ANALYSIS
            17.1.2. Thermo Fisher Scientific
                      17.1.2.1. Company Description
                      17.1.2.2. Financial Overview
                      17.1.2.3. Strategic Overview
                      17.1.2.4. Recent Developments
                      17.1.2.5. SWOT ANALYSIS
            17.1.3. PerkinElmer Inc.
                      17.1.3.1. Company Description
                      17.1.3.2. Financial Overview
                      17.1.3.3. Strategic Overview
                      17.1.3.4. Recent Developments
                      17.1.3.5. SWOT ANALYSIS
            17.1.4. Biogen Inc.
                      17.1.4.1. Company Description
                      17.1.4.2. Financial Overview
                      17.1.4.3. Strategic Overview
                      17.1.4.4. Recent Developments
                      17.1.4.5. SWOT ANALYSIS
            17.1.5. Boehringer Ingelheim GmbH 
                      17.1.5.1. Company Description
                      17.1.5.2. Financial Overview
                      17.1.5.3. Strategic Overview
                      17.1.5.4. Recent Developments
                      17.1.5.5. SWOT ANALYSIS
            17.1.6. Insilico Medicine, Inc.
                      17.1.6.1. Company Description
                      17.1.6.2. Strategic Overview
                      17.1.6.3. SWOT ANALYSIS
            17.1.7. International Business Machines Corporation
                      17.1.7.1. Company Description
                      17.1.7.2. Financial Overview
                      17.1.7.3. Strategic Overview
                      17.1.7.4. SWOT ANALYSIS
            17.1.8. Schrödinger, LLC
                      17.1.8.1. Company Description
                      17.1.8.2. Strategic Overview
                      17.1.8.3. SWOT ANALYSIS
            17.1.9. Albany Molecular Research Inc. (AMRI)
                      17.1.9.1. Company Description
                      17.1.9.2. Strategic Overview
                      17.1.9.3. SWOT ANALYSIS
            17.1.10. Certara, L.P
                      17.1.10.1. Company Description
                      17.1.10.2. Strategic Overview
                      17.1.10.3. SWOT ANALYSIS

List of Tables

Table 1: Opportunity Map, 2016
Table 2: Opportunity Map, 2016
Table 3: Opportunity Map, 2016
Table 4: Opportunity Map, 2016
Table 5: Global Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 6: Global Drug Discovery Informatics Market mode (US$ Mn) Forecast, by Mode, 2015–2025
Table 7: Global Drug Discovery Informatics Market (US$ Mn) Forecast, by Function, 2015–2025
Table 8: Global Drug Discovery Informatics Market Size (US$ Mn) Forecast, by End-User, 2015–2025
Table 9: Global Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 10: North America Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Product, 2015–2025
Table 11: North America Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Mode, 2015–2025
Table 12: North America Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Function, 2015–2025
Table 13: North America Drug Discovery Informatics Market Value (US$ Mn) Forecast, by End-User, 2015–2025
Table 14: North America Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 15: Europe Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Product, 2015–2025
Table 16: Europe Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Mode, 2015–2025
Table 17: Europe Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Function, 2015–2025
Table 18: Europe Drug Discovery Informatics Market Value (US$ Mn) Forecast, by End-User, 2015–2025
Table 19: Europe drug discovery informatics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 20: Asia Pacific Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Product, 2015–2025
Table 21: Asia Pacific Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Mode, 2015–2025
Table 22: Asia Pacific Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Function, 2015–2025
Table 23: Asia Pacific Drug Discovery Informatics Market Value (US$ Mn) Forecast, by End-User, 2015–2025
Table 24: Asia Pacific drug discovery informatics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 25: Latin America Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Product, 2015–2025
Table 26: Latin America Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Mode, 2015–2025
Table 27: Latin America Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Function, 2015–2025
Table 28: Latin America Drug Discovery Informatics Market Value (US$ Mn) Forecast, by End-User, 2015–2025
Table 29: Latin America drug discovery informatics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 30: Middle East & Africa Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Product, 2015–2025
Table 31: Middle East & Africa Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Mode, 2015–2025
Table 32: Middle East & Africa Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Function, 2015–2025
Table 33: Middle East & Africa Drug Discovery Informatics Market Value (US$ Mn) Forecast, by End-User, 2015–2025
Table 34: Middle East & Africa drug discovery informatics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025

List of Figures

Figure 01: Global Drug Discovery Informatics Market, by Product, Market mode (US$ Mn), 2016 (A)
Figure 02: Global Drug Discovery Informatics Market Revenue (%), by Mode, 2016 (A)
Figure 03: Global Drug Discovery Informatics Market (US$ Mn) Forecast, 2015–2025
Figure 04: Global Drug Discovery Informatics Market Value Share, by product (2016)
Figure 05: Global Drug Discovery Informatics Market Value Share, by mode (2016)
Figure 06: Global Drug Discovery Informatics Market Value Share, by function (2016)
Figure 07: Global Drug Discovery Informatics Market Value Share, by end-user (2016)
Figure 08: Global Drug Discovery Informatics Market Value Share, by Product, 2016 and 2025
Figure 09: Global Drug Discovery Informatics Market Attractiveness, by Product, 2017–2025
Figure 10: Global Drug Discovery Informatics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Discovery Informatics, 2015–2025
Figure 11: Global Drug Discovery Informatics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Development Informatics, 2015–2025
Figure 12: Global Drug Discovery Informatics Market Value Share, by Mode, 2016 and 2025
Figure 13: Global Drug Discovery Informatics Market Attractiveness, by Mode, 2017–2025
Figure 14: Global Drug Discovery Informatics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by In-House Informatics, 2015–2025
Figure 15: Global Drug Discovery Informatics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Outsourced Informatics, 2015–2025
Figure 16: Global Drug Discovery Informatics Market Value Share, by Function, 2016 and 2025
Figure 17: Global Drug Discovery Informatics Market Attractiveness, by Function, 2017–2025
Figure 18: Global Drug Discovery Informatics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Sequencing and Target Data Analysis, 2015–2025
Figure 19: Global Drug Discovery Informatics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Docking, 2015–2025
Figure 20: Global Drug Discovery Informatics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Lead Generation Informatics, 2015–2025
Figure 21: Global Drug Discovery Informatics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Identification & Validation Informatics, 2015–2025
Figure 22: Global Drug Discovery Informatics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Molecular Modelling, 2015–2025
Figure 23: Global Drug Discovery Informatics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
Figure 24: Global Drug Discovery Informatics Market Value Share, by End-User, 2016 and 2025
Figure 25: Global Drug Discovery Informatics Market Attractiveness, by End-User, 2017–2025
Figure 26: Global Drug Discovery Informatics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pharmaceutical & Biotechnology Companies, 2015–2025
Figure 27: Global Drug Discovery Informatics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Contract Research Organizations, 2015–2025
Figure 28: Global Drug Discovery Informatics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
Figure 29: Global Drug Discovery Informatics Market Value Share, by Region, 2017 and 2025
Figure 30: Global Drug Discovery Informatics Market Attractiveness, by Region, 2017–2025
Figure 31: North America Drug Discovery Informatics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2025
Figure 32: North America Drug Discovery Informatics Market Value Share Analysis, by Product, 2016 and 2025
Figure 33: North America Drug Discovery Informatics Market Value Share Analysis, by Mode, 2016 and 2025
Figure 34: North America Drug Discovery Informatics Market Value Share Analysis, by Function, 2016 and 2025
Figure 35: North America Drug Discovery Informatics Market Value Share Analysis, by End-User, 2016 and 2025
Figure 36: North America Drug Discovery Informatics Market Value Share Analysis, by Country, 2016 and 2025
Figure 37: North America Drug Discovery Informatics Market Attractiveness Analysis, by Product
Figure 38: North America Drug Discovery Informatics Market Attractiveness Analysis, by Mode
Figure 39: North America Drug Discovery Informatics Market Attractiveness Analysis, by Function
Figure 40: North America Drug Discovery Informatics Market Attractiveness Analysis, by End-user
Figure 41: North America Drug Discovery Informatics Market Attractiveness Analysis, by Country
Figure 42: Europe Drug Discovery Informatics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2025
Figure 43: Europe Drug Discovery Informatics Market Value Share Analysis, by Product, 2016 and 2025
Figure 44: Europe Drug Discovery Informatics Market Value Share Analysis, by Mode, 2016 and 2025
Figure 45: Europe Drug Discovery Informatics Market Value Share Analysis, by Function, 2016 and 2025
Figure 46: Europe Drug Discovery Informatics Market Value Share Analysis, by End-User, 2016 and 2025
Figure 47: Europe drug discovery informatics Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 48: Europe Drug Discovery Informatics Market Attractiveness Analysis, by Product
Figure 49: Europe Drug Discovery Informatics Market Attractiveness Analysis, by Mode
Figure 50: Europe Drug Discovery Informatics Market Attractiveness Analysis, by Function
Figure 51: Europe Drug Discovery Informatics Market Attractiveness Analysis, by End-user
Figure 52: Europe Drug Discovery Informatics Market Attractiveness Analysis, by Country
Figure 53: Asia Pacific Drug Discovery Informatics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2025
Figure 54: Asia Pacific Drug Discovery Informatics Market Value Share Analysis, by Product, 2016 and 2025
Figure 55: Asia Pacific Drug Discovery Informatics Market Value Share Analysis, by Mode, 2016 and 2025
Figure 56: Asia Pacific Drug Discovery Informatics Market Value Share Analysis, by Function, 2016 and 2025
Figure 57: Asia Pacific Drug Discovery Informatics Market Value Share Analysis, by End-User, 2016 and 2025
Figure 58: Asia Pacific drug discovery informatics Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 59: Asia Pacific Drug Discovery Informatics Market Attractiveness Analysis, by Product
Figure 60: Asia Pacific Drug Discovery Informatics Market Attractiveness Analysis, by Mode
Figure 61: Asia Pacific Drug Discovery Informatics Market Attractiveness Analysis, by Function
Figure 62: Asia Pacific Drug Discovery Informatics Market Attractiveness Analysis, by End-user
Figure 63: Asia Pacific Drug Discovery Informatics Market Attractiveness Analysis, by Country/Sub Region
Figure 64: Latin America Drug Discovery Informatics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2025
Figure 65: Latin America Drug Discovery Informatics Market Value Share Analysis, by Product, 2016 and 2025
Figure 66: Latin America Drug Discovery Informatics Market Value Share Analysis, by Mode, 2016 and 2025
Figure 67: Latin America Drug Discovery Informatics Market Value Share Analysis, by Function, 2016 and 2025
Figure 68: Latin America Drug Discovery Informatics Market Value Share Analysis, by End-User, 2016 and 2025
Figure 69: Latin America drug discovery informatics Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 70: Latin America Drug Discovery Informatics Market Attractiveness Analysis, by Product
Figure 71: Latin America Drug Discovery Informatics Market Attractiveness Analysis, by Mode
Figure 72: Latin America Drug Discovery Informatics Market Attractiveness Analysis, by Function
Figure 73: Latin America Drug Discovery Informatics Market Attractiveness Analysis, by End-user
Figure 74: Latin America Drug Discovery Informatics Market Attractiveness Analysis, by Country
Figure 75: Middle East & Africa Drug Discovery Informatics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2025
Figure 76: Middle East & Africa Drug Discovery Informatics Market Value Share Analysis, by Product, 2016 and 2025
Figure 77: Middle East & Africa Drug Discovery Informatics Market Value Share Analysis, by Mode, 2016 and 2025
Figure 78: Middle East & Africa Drug Discovery Informatics Market Value Share Analysis, by Function, 2016 and 2025
Figure 79: Middle East & Africa Drug Discovery Informatics Market Value Share Analysis, by End-User, 2016 and 2025
Figure 80: Middle East & Africa drug discovery informatics Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 81: Middle East & Africa Drug Discovery Informatics Market Attractiveness Analysis, by Product
Figure 82: Middle East & Africa Drug Discovery Informatics Market Attractiveness Analysis, by Mode
Figure 83: Middle East & Africa Drug Discovery Informatics Market Attractiveness Analysis, by Function
Figure 84: Middle East & Africa Drug Discovery Informatics Market Attractiveness Analysis, by End-user
Figure 85: Middle East & Africa Drug Discovery Informatics Market Attractiveness Analysis, by Country

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Drug Discovery Informatics Market